InnoHubサポーター団体
Refined search
Refined search- Display Switch
-
- Pharmaceutical manufacturer
Huons Global
-
- Pharmaceutical manufacturer
TMS Co., Ltd.
-
- Pharmaceutical manufacturer
Nippon Boehringer Ingelheim Co., Ltd.
-
- Pharmaceutical manufacturer
Otsuka Pharmaceutical Co., Ltd.
-
- Pharmaceutical manufacturer
Eisai Co. Ltd.,
-
- Pharmaceutical manufacturer
UCB Japan Co.,Ltd.
-
- Pharmaceutical manufacturer
-
-
- Pharmaceutical manufacturer
Astellas Pharma Inc.
-
- Pharmaceutical manufacturer
Ono Pharmaceutical Co., Ltd.
-
- Pharmaceutical manufacturer
-
-
- Pharmaceutical manufacturer
Taisho Pharmaceutical Holdings
-
- Pharmaceutical manufacturer
CMIC HOLDINGS Co., LTD
-
- Pharmaceutical manufacturer
Novartis AG
-
- Pharmaceutical manufacturer
KOWA
-
- Pharmaceutical manufacturer
-
-
- Pharmaceutical manufacturer
Mitsubishi Tanabe Pharma
-
- Pharmaceutical manufacturer
-
Huons Global
- Industry
-
- Pharmaceutical manufacturer
- Introduction
Industry
Introduction
TMS Co., Ltd.
- Industry
-
- Pharmaceutical manufacturer
- Introduction
Nippon Boehringer Ingelheim Co., Ltd.
- Industry
-
- Pharmaceutical manufacturer
- Introduction
Otsuka Pharmaceutical Co., Ltd.
- Industry
-
- Pharmaceutical manufacturer
- Introduction
- -
Eisai Co. Ltd.,
- Industry
-
- Pharmaceutical manufacturer
- Introduction
- -
UCB Japan Co.,Ltd.
- Industry
-
- Pharmaceutical manufacturer
- Introduction
- -
-
- Industry
-
- Pharmaceutical manufacturer
- Introduction
- -
Astellas Pharma Inc.
- Industry
-
- Pharmaceutical manufacturer
- Introduction
- Under its Corporate Strategic Plan 2018, Astellas is committed to “Developing Rx+® programs.” Astellas leverages strengths acqired through prescription drug (Rx) development and integrates innovative medical technology with cutting-edge technology in different fields, toward a new Rx+® solution. When collaborating with partners, we are flexible in approach, open to not only joint research and development, but also investment and asset acquisition. https://www.astellas.com/jp/en/partnering/rx-plus
Ono Pharmaceutical Co., Ltd.
- Industry
-
- Pharmaceutical manufacturer
- Introduction
- ONO has taken a new step beyond the major milestone of the 300th anniversary , since its establishment in 1717.
Upholding the corporate philosophy “Dedicated to Man’s Fight against Disease and Pain,” we make united efforts to create innovative drugs that are globally competitive.
-
- Industry
-
- Pharmaceutical manufacturer
- Introduction
- -
Taisho Pharmaceutical Holdings
- Industry
-
- Pharmaceutical manufacturer
- Introduction
- -
CMIC HOLDINGS Co., LTD
- Industry
-
- Pharmaceutical manufacturer
- Introduction
- -
Novartis AG
- Industry
-
- Pharmaceutical manufacturer
- Introduction
- -
KOWA
- Industry
-
- Pharmaceutical manufacturer
- Introduction
- We are looking for collaborations with startups in healthcare (medicine, medical equipment, sanitary goods), food, environment, and hospitality fields. We are also interested in building new business models utilizing AI and IoT.
-
- Industry
-
- Pharmaceutical manufacturer
- Introduction
- As we are doing a wide range of businesses in the healthcare field as a comprehensive healthcare company, we will support you by utilizing our business knowledge.
Mitsubishi Tanabe Pharma
- Industry
-
- Pharmaceutical manufacturer
- Introduction
- We hope that this program enables us to draw up innovative business models for solving the global issues by generating new business .
We are interested in the areas of central nervous system, immuno-inflammation, diabetes, and healthcare aimed at disease prevention.
-
- Industry
-
- Pharmaceutical manufacturer
- Introduction
- Over the years, the Glico Group has become increasingly active in business areas such as confectionery, frozen desserts, dairy products and processed foods and has recently been focusing on further developments in the areas of beverages and other products that support the healthy growth of infants, products that support health with various consumer lifestyles and health functional food materials.
